Thymic carcinoma diagnostic study of choice
|
Thymic Carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymic carcinoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Thymic carcinoma diagnostic study of choice |
|
Risk calculators and risk factors for Thymic carcinoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [3]
Overview
The staging of thymic carcinoma is based on the Masoka and GETT staging system.[1]
Diagnostic study of choice
 |
The diagnostic study of choice for thymic carcinoma is tissue biopsy.[2]
References
- ↑ Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S; et al. (1994). "Thymectomy and malignancy". Eur J Cardiothorac Surg. 8 (5): 251–3. PMID 8043287.
- ↑ Akiyama T, Miyamoto Y, Nomoto D, Kiyozumi Y, Eto K, Hiyoshi Y; et al. (2019). "Laparoscopic dissection for pelvic lymph node recurrence of thymic carcinoma: A case report". Asian J Endosc Surg. doi:10.1111/ases.12688. PMID 30714349.